Skip to main content
OpenTrials

Clinical trial condition

Transitional Cell Cancer of the Renal Pelvis and Ureter

Explore clinical trials studying Transitional Cell Cancer of the Renal Pelvis and Ureter. Study availability and eligibility vary by location and protocol.

32 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Transitional Cell Cancer of the Renal Pelvis and Ureter trial results

Completed

Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter

NCT00066352

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • University of Chicago Cancer Research Center Chicago, Illinois, United States
  • Decatur Memorial Hospital Cancer Care Institute Decatur, Illinois, United States
  • CCOP - Evanston Evanston, Illinois, United States
  • Ingalls Cancer Care Center at Ingalls Memorial Hospital Harvey, Illinois, United States
View all 15 locations
View Trial Details
Completed

Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer

NCT00003175

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Porto Alegre Hospital Porto Alegre, Rio Grande do Sul, Brazil
  • Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada
  • Mount Sinai Hospital - Toronto Toronto, Ontario, Canada
  • Princess Margaret Hospital Toronto, Ontario, Canada
View all 62 locations
View Trial Details
Completed

R115777 in Treating Patients With Advanced Bladder Cancer

NCT00006376

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
View Trial Details
Completed

Oxaliplatin in Treating Patients With Metastatic Bladder Cancer

NCT00004203

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • University of Illinois at Chicago Chicago, Illinois, United States
  • University of Chicago Cancer Research Center Chicago, Illinois, United States
  • Louis A. Weiss Memorial Hospital Chicago, Illinois, United States
  • Cancer Care Specialists of Central Illinois, S.C. Decatur, Illinois, United States
View all 14 locations
View Trial Details

Related conditions